Group items tagged

MarketsandMarkets Conferences is Organizing the 9th Annual High Potent Medicines Conference - EU Edition which will be held from May 22 - 24, 2024 in Milan, Italy.

Medical robots are increasingly being adopted by hospitals and patients across the globe, particularly in the U.S. Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stimulate growth the adoption of medical robots.

The protein labeling market is expected to reach USD 1,894.5 Million by 2020 from USD 1,089.5 Million in 2015, growing at a CAGR of 11.7% from 2015 to 2020. A strong trend of increasing healthcare expenditure will majorly drive the growth of the market. Other growth factors include increasing R&D spending and growth in proteomics research. The increasing use of protein labeling in in vitro labeling, in vivo labeling, and bioorthogonal labeling methods will provide opportunities for market growth.

Laboratory centrifuge are used for various applications by different end users. A centrifuge is a type of equipment with an inbuilt motor, and is used for spinning the liquid samples at a high speed. This is aimed at separating the various components comprising the liquid. This equipment is widely used in laboratories for various research purposes in the areas of chemistry, biology, and biochemistry.

market is expected to witness rapid growth owing to the increasing number of breast cancer surgeries and implementation of favorable reimbursement guidelines for localization devices. However, uncertainty in regulatory approval procedures due to risks associated with breast lesion localization devices is expected to restrain the growth of this market.

Surface disinfectants are chemical formulations that eliminate microorganisms from surfaces or significantly decrease the possibility of their transfer through hand contact between surfaces. These include bedside tables, chairs, walls, floors, and medical equipment (clinical contact surfaces). The global surface disinfectant market is expected to reach USD 789.1 Million by 2022 from USD 529.6 Million in 2017, at a CAGR of 8.3%. Increasing number of surgical procedures, rising geriatric population, and subsequent growth in the prevalence of chronic diseases are the major driving factors for this market.

The medical gases product segment accounted for largest share of the medical gases market in 2015. Population growth and aging population, coupled with the increasing prevalence of chronic diseases such as COPD and sleep apnea, are the growth drivers contributing to the growth of the medical gas and equipment market. Moreover, increasing healthcare awareness and affordability, backed by rising healthcare spending in developing countries, is expected to contribute to the growth of this market during the forecast period.

By application, joint pain accounted for the largest market share in 2017 Based on application, the veterinary pain management market has been segmented into joint pain, postoperative pain, cancer, and other applications. Other applications include traumatic pain, abdominal pain, neuropathic pain, dermatological pain, and mastitis. In 2017, joint pain held the largest share of the veterinary pain management market. The dominant share of this application segment has been attributed to the growing pet population, rising prevalence of osteoarthritis and musculoskeletal disorders in animals, and the increasing population of obese and overweight pets.

The Market Research on Vascular Graft, By Considering useful aspects like; Material, Product, Application, End User - Global Future Forecast till 2023, published by MarketsandMarkets™, the report studies the global Vascular Graft market over the forecast period of 2017 to 2023. The market is projected to reach USD 3.80 Billion by 2023 at a CAGR of 7.3%.

The Veterinary Software Report Provide SWOT analysis to understand Strengths, Weaknesses, Opportunities, and Threats of the Veterinary Software industry along with competitive Analysis. Along with, analysis of upstream raw materials and downstream consumers are also conducted in Veterinary Software research study. Global Veterinary Software market influences various other factors such as globalization, improvements in trade and income, and commercialization to enhance extensive growth.

The cerebrospinal fluid (CSF) management market is segmented by product, end user, and region. Based on product, the market is segmented into shunts and external drainage systems. The shunts market is expected to grow at the highest CAGR during the forecast period. The high growth in the shunts market can be primarily attributed to the growing number of shunting procedures performed worldwide as well as the increasing number of revision shunt surgeries. Based on the type, the shunts segment is further segmented into ventriculoperitoneal (VP), ventriculoatrial (VA), lumboperitoneal (LP), and ventriculopleural (VPL).

The market is broadly segmented into instruments, assays & kits, and services & software based on the basis of products & services. The assays & kits segment is expected to account for the largest share of the global POC molecular diagnostics market. This segment is also projected to register the highest CAGR during the forecast period. Based on the applications, the market is segmented into respiratory diseases, hospital-acquired infections (HAIs), sexually transmitted diseases (STDs), oncology, hepatitis, and other applications (meningococcal meningitis, malaria, Herpes Simplex Virus, Ebola, Zika virus).

The Market Research on Wound Debridement, By Considering useful aspects like; Material, Product, Application, End User (Hospital, ASCs) - Global Future Forecast till 2023, published by MarketsandMarkets™, the report studies the global Wound Debridement market over the forecast period of 2017 to 2023. The market is projected to reach USD 1,041.0 Million by 2023 at a CAGR of 8.2%.

The Global Magnetic Resonance Imaging (MRI) System Market Research Report 2018 gives an in-depth valuation of the Magnetic Resonance Imaging (MRI) System that includes technologies, key trends, market share, size, challenges, opportunities, future forecast, value chain, and strategies. The Research report gives a complete overview of the market and contains a Future trend, Current Growth Factors. The study is segmented by products type, application/end-users.

The global enteral feeding formulas market is estimated to reach USD 5.95 Billion by 2020, growing at a CAGR of 7.6% during the forecast period. The market is mainly driven by the rising incidences of chronic diseases and disorders, the rapidly increasing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. On the other hand, factors such as complications associated with enteral nutrition, patient safety risks, and the risk of feeding and medication errors are some factors that are expected to limit the growth of the enteral feeding formulas market in the coming years.

he global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.33 Billion in 2018, at CAGR of 7.5%. Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay. The use of multiplex assays in companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays are driving the growth of the market.

The clinical decision support systems market is projected to reach USD 1,752.0 Million by 2023 from USD 901.0 Million in 2017, at a CAGR of 11.8%. Factors such as government support & initiatives, growing incidence of medication errors, rising prominence & usage of big data and mhealth tools, high returns on investment for CDSS solutions, and growing adoption of cloud computing in healthcare are driving the growth of this market.

The microfluidics market is valued at 8.28 Billion in 2017 and is expected to grow at a CAGR of 22.6% during the forecast period, to reach to USD 27.91 Billion by 2023. Base year considered for the report is 2017 and the forecast period includes 2018 to 2023. The increasing incidence of other major chronic and infectious diseases, coupled with advancements in coagulation tests, blood gas electrolytes, hematology, urine chemistry, and cardiac markers, are creating new avenues for the growth of the POC diagnostics market. This, in turn, is expected to support the growth of the microfluidics market as POC testing is the largest segment of the microfluidics market for in vitro diagnostics.